F-Prime

F-Prime Capital is a leading global venture capital firm with roots in Fidelity Investments, founded in 1969. The firm specializes in early- to growth-stage investments across various sectors, including healthcare, life sciences, technology, healthtech & services, and cryptocurrency. With over $4.5 billion in assets under management and a portfolio exceeding 300 companies, F-Prime supports visionary entrepreneurs and academics in developing breakthrough innovations that transform medicine and technology worldwide.

The firm operates with a stage-agnostic investment approach, backing exceptional teams at any stage from seed to late-stage. Its investment focus within healthcare includes domains such as therapeutics, medtech, health IT, and services, while in the technology sector, it targets enterprise software, fintech, frontier tech, and cryptocurrency. F-Prime combines deep scientific, engineering, and clinical expertise with operational and strategic support to accelerate scalable growth and maximize impact.

F-Prime maintains a global presence with offices located in Cambridge (MA), San Francisco, and London. The firm collaborates closely with its sister fund, Eight Roads, to extend its reach across Asia, including countries like China, Japan, India, and Israel, as well as across Europe. F-Prime is recognized for creating or co-creating over 30 companies and actively partners with portfolio ventures to provide critical insights, mentorship, and networking opportunities, fostering innovation with a patient, long-term investment philosophy.